Adjournment of General Meeting and New Proxy Deadline
The General Meeting will be reconvened on 
The adjournment is intended to facilitate further commercial discussions between the Company and its principal shareholder in relation to the resolutions prior to the reconvened meeting.
Shareholders are referred to the supporting notes attached to the Notice of General Meeting dated 
Accordingly, the new deadline for submission of proxy appointments to the Company's registrar is 15:30 (GMT) on 
The new deadline for holders of depositary Interests including instruction via Crest system is 15:30 (GMT) on 
Shareholders are strongly encouraged to review the Explanatory Notes to the resolutions being proposed, as set out in Appendix 1 of the Notice of Meeting, and to vote either in person or by appointing the Chairman of the meeting as their proxy.
Failure to pass the proposed resolutions may have a material impact on all shareholders and on the assets of the Company.
Webinar
The Company will stream the reconvened meeting by a webinar that will allow direct access to the meeting from any internet linked computer or smart device. Shareholders can download via the link that will be provided two days before the reconvened meeting on Premier webpage.
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of 
The person who arranged the release of this announcement on behalf of the Company was 
Enquiries:
| 
 | 
 | 
 Tel: +27 (0) 100 201 281  | 
| 
 | 
 (Nominated Adviser)  | 
 Tel: +44 (0) 20 7628 3396  | 
| 
 | 
 | 
 Tel: +44 (0) 20 3003 8632  | 
| 
 | 
 | 
 Tel: +44 (0) 20 7408 4090  | 
Notes to Editors:
The Company has a diverse portfolio of projects, which include tungsten, rare earth elements, lithium and tantalum in 
Nominated Adviser Statement
Beaumont Cornish Limited ("Beaumont Cornish"), which is authorised and regulated in the 
 Ends
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the